Polar Capital Holdings PLC Morphic Holding, Inc. Transaction History

Polar Capital Holdings PLC

  • $16 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$43.27 - $65.72 $3.25 Million - $4.93 Million
75,000 Added 30.0%
325,000 $15.4 Million
Q3 2021

Nov 15, 2021
BUY
$53.61 - $67.5 $5.36 Million - $6.75 Million
100,000 Added 66.67%
250,000 $14.2 Million
Q1 2021

May 17, 2021
BUY
$29.77 - $84.85 $4.47 Million - $12.7 Million
150,000 New
150,000 $9.49 Million

Others Institutions Holding MORF

# of Institutions
142
Shares Held
37.9M
Call Options Held
13.5K
Put Options Held
190K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email